Stay updated with breaking news from Daniels Jonas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONMED Co. (NYSE:CNMD – Free Report) has earned a consensus recommendation of “Moderate Buy” from the four analysts that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price target among brokers that have […]
AMI Asset Management Corp lowered its position in CONMED Co. (NYSE:CNMD – Free Report) by 0.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 47,711 shares of the company’s stock after selling 195 shares during the period. AMI Asset Management Corp’s holdings in CONMED were […]
CL King started coverage on shares of CONMED (NYSE:CNMD – Get Rating) in a research report released on Monday, The Fly reports. The firm issued a buy rating and a $140.00 price objective on the stock. CNMD has been the topic of several other research reports. StockNews.com raised shares of CONMED from a sell rating […]
CONMED Co. (NYSE:CNMD – Get Rating) insider Daniel S. Jonas sold 10,000 shares of CONMED stock in a transaction that occurred on Friday, April 28th. The stock was sold at an average price of $126.10, for a total transaction of $1,261,000.00. Following the completion of the sale, the insider now owns 13,462 shares of the […]
Should You Buy or Sell CONMED Stock? Get The Latest CNMD Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.